Hikma Ventures logo

Hikma Ventures

Europe, England, United Kingdom, London

Description

Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.

Investor Profile

Hikma Ventures has made 25 investments, with 0 in the past 12 months and 28% as lead.

Stage Focus

  • Series A (40%)
  • Series B (28%)
  • Seed (12%)
  • Series C (8%)
  • Series Unknown (4%)
  • Series D (4%)
  • Convertible Note (4%)

Country Focus

  • United States (84%)
  • Canada (8%)
  • United Arab Emirates (4%)
  • Egypt (4%)

Industry Focus

  • Health Care
  • Medical Device
  • Medical
  • Biotechnology
  • Artificial Intelligence (Ai)
  • Health Diagnostics
  • Mhealth
  • Machine Learning
  • Wearables
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hikma Ventures frequently co-invest with?

Safeguard Scientifics
North America, Pennsylvania, United States, Radnor
Co-Investments: 4
Civilization Ventures
North America, California, United States, San Francisco
Co-Investments: 3
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 2
Cigna
North America, Connecticut, United States, Bloomfield
Co-Investments: 2
Aphelion Capital
North America, Colorado, United States, Littleton
Co-Investments: 2
Correlation Ventures
North America, California, United States, San Diego
Co-Investments: 2
LV
North America, New York, United States, New York
Co-Investments: 2
Merck Global Health Innovation Fund
North America, New Jersey, United States, Whitehouse Station
Co-Investments: 2
Cota Capital
North America, California, United States, San Francisco
Co-Investments: 2
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 4

Which angels does Hikma Ventures often collaborate with?

SM
Asia, Haryana, India, Gurgaon
Shared Deals: 1
WH
North America, California, United States, San Francisco
Shared Deals: 1
KG
Asia, Dubai, United Arab Emirates, Dubai
Shared Deals: 1

What are some of recent deals done by Hikma Ventures?

Octave

Menlo Park, California, United States

Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.

BiotechnologyClinical TrialsHealth CareHealth DiagnosticsMedicalPrecision Medicine
Series BJul 26, 2023
Amount Raised: $32,500,070
Prognos Health

New York, New York, United States

Prognos Health creates a healthcare analytics platform that uses patient-level data to generate clinical insights.

AnalyticsHealth CareHealth Diagnostics
Series UnknownMay 4, 2023
Amount Raised: $23,288,367
O7 Therapy

Cairo, Al Qahirah, Egypt

O7 Therapy is revolutionizing access to mental health services through a digital platform and mobile app offering online therapy.

Health CareMedicalMental Health
SeedApr 4, 2022
Amount Raised: $2,100,000
Altoida

Washington, District of Columbia, United States

Altoida is creating a new gold standard in brain health with Precision Neurology.

Artificial Intelligence (AI)Augmented RealityHealth CareHealth DiagnosticsMedicalMedical DevicemHealthSoftware
Series AMar 30, 2022
Amount Raised: $14,000,000
Altibbi

Dubai, Dubai, United Arab Emirates

Altibbi is the Largest Digital Health platform in the Arab World, including 1.5M pages of medical content and a 24/7 telehealth service.

AppsFitnessHealth Care
Series BMar 28, 2022
Amount Raised: $44,000,000
Activ Surgical

Boston, Massachusetts, United States

Activ Surgical is a digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes, and accessibility.

Artificial Intelligence (AI)Health CareMachine LearningMedical DeviceRobotics
Series BMar 22, 2022
Amount Raised: $15,000,000
NuvoAir

Boston, Massachusetts, United States

NuvoAir is a value-based specialty management platform transforming the diagnosis and management of chronic heart and lung conditions.

Health CareMedical
Series AJan 19, 2022
Amount Raised: $11,000,000
BioSapien

New York, New York, United States

BioSapien is a biotech startup focusing on developing a 3D printed drug delivery platform to provide FDA approved drugs.

3D Printing3D TechnologyBiopharmaBiotechnologyPharmaceutical
SeedNov 11, 2021
Amount Raised: $1,800,000
Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series BNov 2, 2021
Amount Raised: $100,000,000
Click Therapeutics

New York, New York, United States

Click Therapeutics delivers safe and effective digital treatments to patients in need.

BiotechnologyHealth CareMedical DevicePharmaceuticalTherapeutics
Series BOct 22, 2021
Amount Raised: $52,000,000